Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Beike Biological Pharmaceutical is a biotechnology company based in China that specializes in the development and manufacturing of cell-based therapies. As a key subsidiary of Shenzhen Beike Biotechnology, the company focuses on the industrialization of adult stem cell technologies, including umbilical cord-derived mesenchymal stem cells. The firm operates large-scale manufacturing facilities that adhere to Good Manufacturing Practice (GMP) standards to support clinical research and therapeutic applications. Its primary business involves providing cell processing services and developing regenerative medicine products for various chronic and degenerative conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Beike Biological Pharmaceutical.